Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia

Neuroscience Letters

Volumn 340, Issue 1, 2003, Pages 69-73

  Johansson, A ^a,g   Hampel, H ^b   Faltraco, F ^b   Buerger, K ^b   Minthon, L ^c   Bogdanovic, N ^d   Sjogren M ^a   Zetterberg, H ^a   Forsell, L ^d   Lilius, L ^d   Wahlund, L O ^d   Rymo, L ^a   Prince, J A ^e   Blennow, K ^a,f  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f MEDICAL RESEARCH COUNCIL   (Sweden)

^g SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cdc2; Frontotemporal dementia; Senile plaques

Indexed keywords

PROTEIN KINASE;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; EXON; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TAUOPATHY;

EID: 0344837798     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00051-X     Document Type: Article

References (17)

1. Bertram L., Blacker D., Mullin K., Keeney D., Jones J., Basu S., Yhu S., McInnis M.G., Go R.C., Vekrellis K., Selkoe D.J., Saunders A.J., Tanzi R.E. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science. 290:2000;2302-2303.
2. Blennow K., Ricksten A., Prince J.A., Brookes A.J., Emahazion T., Wasslavik C., Bogdanovic N., Andreasen N., Batsman S., Marcusson J., Nagga K., Wallin A., Regland B., Olofsson H., Hesse C., Davidsson P., Minthon L., Jansson A., Palmqvist L., Rymo L. No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression. J. Neural Transm. 107:2000;1065-1079.
3. Blennow K., Skoog I. Genetic testing for Alzheimer's disease: how close is reality? Curr. Opin. Psychiatry. 12:1999;487-493.
4. Ertekin-Taner N., Graff-Radford N., Younkin L.H., Eckman C., Baker M., Adamson J., Ronald J., Blangero J., Hutton M., Younkin S.G. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science. 290:2000;2303-2304.
5. Georgi A.B., Stukenberg P.T., Kirschner M.W. Timing of events in mitosis. Curr. Biol. 12:2002;105-114.
6. Hardy J., Gwinn-Hardy K. Genetic classification of primary neurodegenerative disease. Science. 282:1998;1075-1079.
7. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24:2001;1121-1159.
8. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
9. McShea A., Harris P.L., Webster K.R., Wahl A.F., Smith M.A. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am. J. Pathol. 150:1997;1933-1939.
10. Milton N.G. Phosphorylation of amyloid-beta at the serine 26 residue by human cdc2 kinase. NeuroReport. 12:2001;3839-3844.
11. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II, standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
12. Myers A., Holmans P., Marshall H., Kwon J., Meyer D., Ramic D., Shears S., Booth J., DeVrieze F.W., Crook R., Hamshere M., Abraham R., Tunstall N., Rice F., Carty S., Lillystone S., Kehoe P., Rudrasingham V., Jones L., Lovestone S., Perez-Tur J., Williams J., Owen M.J., Hardy J., Goate A.M. Susceptibility locus for Alzheimer's disease on chromosome 10. Science. 290:2000;2304-2305.
13. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., Kertesz A., Robert P.H., Albert M., Boone K., Miller B.L., Cummings J., Benson D.F. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 51:1998;1546-1554.
14. Niu T., Qin Z.S., Xu X., Liu J.S. Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am. J. Hum. Genet. 70:2002;157-169.
15. Suzuki T., Oishi M., Marshak D.R., Czernik A.J., Nairn A.C., Greengard P. Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBOJ. 13:1994;1114-1122.
16. Tsujioka Y., Takahashi M., Tsuboi Y., Yamamoto T., Yamada T. Localization and expression of cdc2 and cdk4 in Alzheimer brain tissue. Dement. Geriatr. Cogn. Disord. 10:1999;192-198.
17. Wood J.G., Lu Q., Reich C., Zinsmeister P. Proline-directed kinase systems in Alzheimer's disease pathology. Neurosci. Lett. 156:1993;83-86.